Skip to content

SCC Times

Bringing you the Best Analytical Legal News

Site navigation

Home
News
OP. ED.
Experts Corner
Case Briefs
Legislation
Legal RoundUp
Cases
Law School News
Law made Easy
Know thy Judge
Interviews
Mental Health
- Articles
- A Talk
Book Reviews
Watch Now
Subscribe

New Venture

Business News News

Pfizer to combine off-patent drug business with Mylan

As reported by CNBC, Pfizer is set to combine its off-patent drug business with Mylan– a generic drugmaker. Pfizer shareholders would own

Published on July 30, 2019July 30, 2019By Bhumika Indulia

Leave a comment2994 views

Advertisement

Advertisement

SUBSCRIBE OUR NEWSLETTER for Latest Updates including Case Briefs, Legislation Updates, Law School News, Experts Corner and a lot more

Subscribe to our Newsletter

Get weekly latest news and updates in your e-mail

Subscribe to our Newsletter

Get weekly latest news and updates in your e-mail

News Submissions

blog@scconline.com

Article Submissions

articles@scconline.com

Download SCC Online App for Android Users/IOS Users

Disclaimer : The content of this Blog are for informational purposes only and for the reader's personal non-commercial use. The views expressed are not the personal views of EBC Publishing Pvt. Ltd. and do not constitute legal advice. The contents are intended, but not guaranteed, to be correct, complete, or up to date. EBC Publishing Pvt. Ltd. disclaims all liability to any person for any loss or damage caused by errors or omissions, whether arising from negligence, accident or any other cause.

© EBC Publishing Pvt. Ltd. All rights reserved.

×